Multinationals willing to expand direct transactions with wholesalers

17 multinational drug manufacturers, including Novartis Korea, GlaxoSmithKline, Lilly Korea, Boehringer Ingelheim Korea, Sanofi-Aventis Korea and Pfizer Korea, agreed to address the sensitive Zuellig issue in a meeting on June 13, which was arranged by the Korea Pharmaceutical Wholesalers Association.

If Zuellig Pharma Korea and 30 associate wholesalers fail to reach a mutual agreement and t...